We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$617M
AUM Growth
-$413M
Cap. Flow
-$455M
Cap. Flow %
-73.77%
Top 10 Hldgs %
54.35%
Holding
5,864
New
1,647
Increased
1,144
Reduced
1,785
Closed
1,178

Sector Composition

Rank Sector Weight
1 Financials 1.97%
2 Technology 1.44%
3 Real Estate 1.39%
4 Energy 1.34%
5 Industrials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GF
4051
New Germany Fund
GF
$188M
$1K ﹤0.01%
95
-326
-77% -$4.93K
GLBZ
4052
DELISTED
Glen Burnie Bancorp
GLBZ
$1K ﹤0.01%
53
-37
-41% -$462
GLO
4053
Clough Global Opportunities Fund
GLO
$257M
$1K ﹤0.01%
97
-135
-58% -$1.48K
GNK icon
4054
Genco Shipping & Trading
GNK
$1.1B
$1K ﹤0.01%
69
-14
-17% -$303
GPRE icon
4055
Green Plains
GPRE
$1.03B
$1K ﹤0.01%
33
-82
-71% -$1.74K
GRID
4056
First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund
GRID
$12.1B
$1K ﹤0.01%
43
-163
-79% -$5.35K
GROW icon
4057
US Global Investors
GROW
$38.5M
$1K ﹤0.01%
905
+846
+1,434% +$1.15K
HAE icon
4058
Haemonetics
HAE
$4B
$1K ﹤0.01%
+35
New +$1.14K
HDEF icon
4059
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.36B
$1K ﹤0.01%
+39
New +$919
HEQ
4060
John Hancock Hedged Equity & Income Fund
HEQ
$140M
$1K ﹤0.01%
100
+81
+426% +$1.2K
HISF icon
4061
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$99M
$1K ﹤0.01%
14
-295
-95% -$13.9K
HPS
4062
John Hancock Preferred Income Fund III
HPS
$458M
$1K ﹤0.01%
+40
New +$684
HQL
4063
abrdn Life Sciences Investors
HQL
$627M
$1K ﹤0.01%
+44
New +$1.09K
HRTX icon
4064
Heron Therapeutics
HRTX
$92.9M
$1K ﹤0.01%
+53
New +$1.42K
HYI
4065
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
$1K ﹤0.01%
+98
New +$1.4K
PPLI
4066
People Inc
PPLI
$3.1B
$1K ﹤0.01%
+50
New +$579
IBIO icon
4067
iBio
IBIO
$70M
0
IJR icon
4068
iShares Core S&P Small-Cap ETF
IJR
$112B
$1K ﹤0.01%
20
-195,542
-100% -$11M
INN
4069
Summit Hotel Properties
INN
$700M
$1K ﹤0.01%
+100
New +$1.27K
INSE icon
4070
Inspired Entertainment
INSE
$175M
$1K ﹤0.01%
100
-77
-44% -$751
INVA icon
4071
Innoviva
INVA
$1.48B
$1K ﹤0.01%
142
-8,132
-98% -$74.8K
IRIX icon
4072
IRIDEX
IRIX
$14.5M
$1K ﹤0.01%
+115
New +$1.03K
IROQ
4073
DELISTED
IF Bancorp
IROQ
$1K ﹤0.01%
31
-633
-95% -$11.1K
IRWD icon
4074
Ironwood Pharmaceuticals
IRWD
$714M
$1K ﹤0.01%
150
-340
-69% -$3.29K
JAKK icon
4075
Jakks Pacific
JAKK
$293M
$1K ﹤0.01%
13
-84
-87% -$6.84K

Similar funds

Tower Research Capital (TRC)'s Q4 2015 Portfolio in Review

As of Q4 2015, Tower Research Capital (TRC) held 5,864 positions worth $617M, down 40% from $1.03B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $455M in Q4 2015, closing 1,178 positions and reducing 1,785 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2% of assets, down from 2.2% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Tower Research Capital (TRC) opened a new position in ProShares Short S&P500 worth $5.21M.

  • Tower Research Capital (TRC)'s largest Q4 2015 buy was ProShares Short S&P500: 31,192 shares worth $5.21M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2015, an estimated $17.5M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $203M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q4 2015, selling an estimated $28.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $617M portfolio in Q4 2015.
  • Tower Research Capital (TRC) opened 1,647 new positions and closed 1,178 in Q4 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 40% quarter-over-quarter to $617M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.